Is ICU Medical Inc (ICUI) overvalued? · P/E 74, rev $2.38B
ICU Medical Inc (ICUI) is a medical instruments & supplies company listed on NASDAQ.
This page asks whether ICU Medical Inc (ICUI) looks expensive on cached numbers — not a short thesis.
Latest reported ICUI revenue for 2024-12-31 was $2.38B. Net income was -$117.7M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. ICUI currently screens at market cap $3.45B and trailing P/E 73.8.
ICUI currently screens at market cap $3.45B and trailing P/E 73.8. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ICUI 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ICUI stock page for the full model, not this heading.
Not investment advice.